Alliancebernstein L.P. Sells 1,640 Shares of Astrana Health, Inc. (NASDAQ:ASTH)

Alliancebernstein L.P. trimmed its holdings in shares of Astrana Health, Inc. (NASDAQ:ASTH) by 3.1% in the fourth quarter, according to the company in its most recent filing with the SEC. The institutional investor owned 50,500 shares of the company’s stock after selling 1,640 shares during the quarter. Alliancebernstein L.P. owned 0.09% of Astrana Health worth $1,592,000 as of its most recent filing with the SEC.

A number of other large investors have also bought and sold shares of ASTH. KBC Group NV boosted its holdings in shares of Astrana Health by 108.4% in the fourth quarter. KBC Group NV now owns 2,530 shares of the company’s stock valued at $80,000 after buying an additional 1,316 shares during the period. US Bancorp DE lifted its position in Astrana Health by 3,880.0% in the 4th quarter. US Bancorp DE now owns 4,776 shares of the company’s stock valued at $151,000 after acquiring an additional 4,656 shares in the last quarter. Pictet Asset Management Holding SA boosted its stake in Astrana Health by 21.9% in the 4th quarter. Pictet Asset Management Holding SA now owns 7,075 shares of the company’s stock worth $223,000 after purchasing an additional 1,273 shares during the period. Moran Wealth Management LLC increased its holdings in Astrana Health by 21.5% during the 4th quarter. Moran Wealth Management LLC now owns 7,944 shares of the company’s stock worth $250,000 after purchasing an additional 1,404 shares in the last quarter. Finally, Handelsbanken Fonder AB raised its stake in shares of Astrana Health by 4.7% in the 4th quarter. Handelsbanken Fonder AB now owns 8,900 shares of the company’s stock valued at $281,000 after purchasing an additional 400 shares during the period. 52.77% of the stock is owned by institutional investors.

Astrana Health Stock Performance

Shares of ASTH opened at $31.38 on Friday. The company has a market cap of $1.57 billion, a PE ratio of 24.14, a price-to-earnings-growth ratio of 1.37 and a beta of 1.04. The firm has a 50-day moving average of $32.25 and a 200-day moving average of $39.67. Astrana Health, Inc. has a one year low of $23.12 and a one year high of $63.20. The company has a debt-to-equity ratio of 0.60, a current ratio of 1.91 and a quick ratio of 1.91.

Astrana Health (NASDAQ:ASTH) last posted its quarterly earnings results on Thursday, February 27th. The company reported ($0.15) EPS for the quarter, missing analysts’ consensus estimates of $0.22 by ($0.37). The business had revenue of $665.21 million for the quarter, compared to the consensus estimate of $617.24 million. Astrana Health had a return on equity of 9.37% and a net margin of 3.63%. As a group, equities analysts forecast that Astrana Health, Inc. will post 1.15 earnings per share for the current year.

Analysts Set New Price Targets

Several research analysts have recently weighed in on ASTH shares. Truist Financial reduced their price objective on Astrana Health from $50.00 to $46.00 and set a “buy” rating for the company in a research report on Tuesday, March 18th. Stifel Nicolaus reduced their price target on Astrana Health from $70.00 to $56.00 and set a “buy” rating for the company in a research report on Thursday, February 20th. Barclays began coverage on shares of Astrana Health in a report on Tuesday, April 1st. They issued an “equal weight” rating and a $36.00 price objective on the stock. Bank of America cut their price objective on shares of Astrana Health from $55.00 to $49.00 and set a “buy” rating on the stock in a research report on Tuesday, March 4th. Finally, Robert W. Baird decreased their target price on shares of Astrana Health from $86.00 to $50.00 and set an “outperform” rating for the company in a research report on Monday, March 3rd. Three investment analysts have rated the stock with a hold rating, six have given a buy rating and one has assigned a strong buy rating to the company’s stock. According to MarketBeat, the stock currently has a consensus rating of “Moderate Buy” and a consensus price target of $53.29.

Astrana Health Company Profile

Astrana Health, Inc, Inc, a physician-centric technology-powered healthcare management company, provides medical care services in the United States. It operates through three segments: Care Partners, Care Delivery, and Care Enablement. The company is leveraging its proprietary population health management and healthcare delivery platform, operates an integrated, value-based healthcare model which empowers the providers in its network to deliver care to its patients.